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ABSTRACT
We present an unusual case of a delayed right ventricular perforation by a single standard-caliber implantable cardioverter-
defibrillator lead, which manifested 14 days after implantation. Multidetector computed tomography could clearly display 
the lead perforation, and allow for identification of the associated sequelae such as pericardial effusion and planning the lead 
extraction strategy. (Korean Circ J 2011;41:689-691)
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Introduction
Severe complications have been observed more frequently 
in transvenous implantation of implantable cardioverter-de-
fibrillator (ICD) lead than in that of pacemaker, particularly 
in the dual-chamber rather than single-chamber ICD.
1)2) Also, 
perforation of the right ventricular (RV) wall is a rare com-
plication in ICD lead implantation with an estimated incid-
ence of 0.6%. This complication mostly occurs in the peri-
operative period and low incidence of delayed RV wall per-
foration in the subacute phase has been reported.
3) Detection 
of RV wall perforation by standard imaging modalities is of-
ten challenging. Multidetector computed tomography (MD-
CT) is emerging as an optional modality for establishing an 
accurate diagnosis of lead perforation, identifying the extent 
of accompanying complications such as pericardial effusion 
and planning the lead extraction strategy. We present a rare 
case of delayed RV perforation that manifested 14 days after 
ICD implantation and was clearly displayed by MDCT.
Case
An 81-year-old man was referred to our hospital for pre-
syncope, dyspnea and palpitation. He had a previous history 
of inferoposterior myocardial infarction treated by percuta-
neous coronary intervention with drug-eluting stents (DES). 
On arrival, he was conscious and alert but his heart rate was 
190 beats/min and the electrocardiogram (ECG) revealed 
sustained ventricular tachycardia. Intravenous administra-
tion of adenosine or lidocaine did not stabilize the rhythm, 
and electrical cardioversion finally restored a normal sinus 
rhythm. After the recovery of sinus rhythm, the ECG did not 
show ischemic ST-T changes and serum creatine kinase as 
well as troponin T levels were not elevated. The echocardio-
graphy revealed left ventricular (LV) dilatation with LV end-
diastolic/end-systolic dimensions of 66/57 mm, decreased LV 
ejection fraction of 35% and severe ischemic mitral regurgit-
ation. Coronary angiography did not demonstrate any signi-
ficant change compared to the previous findings. The implant-
ation of ICD with an atrial passive-fixation lead (model 5076, 
CapSureFix, Medtronic, Minneapolis, MN, USA) and a stan-
dard-caliber ventricular active-fixation lead (model 6947, Sp-
rint Quattro 8.6- French lead, Medtronic, Minneapolis, MN, 
USA) was performed through the left subclavian vein without 
any complications. The two leads were placed in the right at-
rial appendage and right ventricular apex, respectively (Fig. 1A 
and B). The RV lead parameters were satisfactory (R-wave 690   Delayed Perforation of RV Wall by ICD Lead
amplitude 6.9 mV, pacing threshold 0.4 V at 0.5 ms, pacing 
impedance 380 ohms). After the procedure, dual anti-plate-
let therapy (aspirin 100 mg and ticlopidine 200 mg per day) 
was commenced immediately because of DES implantation 9 
months ago. Echocardiography performed on post-implant 
day 7 showed no significant change without any evidence of 
pericardial effusion.
Fourteen days after ICD implantation, the patient present-
ed to the emergency room with intermittent chest pain since 
the last 2 days. The chest pain appeared to be independent of 
exercise and lasted for 10 to 20 seconds. He was hemodynami-
cally stable. The ECG as well as circulatory biomarker mea-
surements such as creatine kinase and troponin T indicated 
no signs of acute coronary syndrome. The chest X-ray showed 
cardiomegaly and minor changes in the ventricular lead ten-
sion and ventricular lead tip position (Fig. 1C). The echocar-
diography revealed moderate pericardial effusion without 
any significant change in LV wall motion. Interrogation of the 
ICD showed that the sensed R wave measured 6.0 mV, the 
ventricular pacing threshold had risen to 8 V at 0.5 ms and 
pacing impedance had dropped to 282 ohms. Thus, RV per-
foration by the ICD lead was suspected and 64-slice MDCT 
was subsequently performed with a MSCT scanner (VCT, GE 
Healthcare, Milwaukee, WI, USA) according to the following 
protocol: 120 kV, 300 mA, rotation time of 350 to 400 msec 
and collimation of 64×0.625 mm but without contrast-me-
dia to avoid further deterioration of renal function (Fig. 1D). 
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Fig. 1. Chest X-rays in the postero-anterior view (A) and lateral view (B) indicating positions of the atrial and defibrillator leads immediately 
after initial implantation. The defibrillator lead tip (solid arrow) was positioned within the right ventricular apex and the atrial lead tip (dashed 
arrow) was positioned within the right atrial appendage. (C) Chest X-ray 14 days after initial implantation in the emergency department 
showing cardiomegaly and minor changes in ventricular lead tension and ventricular lead tip position (solid arrow). (D) Multidetector com-
puted tomography scan of the thorax showing cardiac perforation by defibrillator lead. The defibrillator lead tip (white arrow), identifiable by 
its radiological density and associated scatter artifacts, extends outwards beyond the right ventricular myocardium into the pericardial sac.
Fig. 2. Intraoperative photograph indicating complete penetration 
of the implantable cardioverter-defibrillator lead tip through the 
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MDCT confirmed complete lead perforation, and because 
of the high bleeding risk due to dual anti-platelet therapy, car-
diac surgery under general anesthesia rather than manual lead 
extraction was indicated (Fig. 2). Lead extraction, closure of 
RV perforation site and re-implantation of the RV lead onto 
the RV outflow tract were successfully performed. The patient 
had an uneventful recovery and has been doing well since 
the last 6 months after discharge. 
Discussion
MDCT allows ready identification of the course of the lead, 
relationship to adjacent anatomy and adverse sequelae such as 
pericardial effusion.
4) This case highlights the role of MDCT 
as an extremely useful imaging modality to confirm the di-
agnosis of lead perforation and planning the lead extraction 
strategy, even without contrast enhancement.
The precise mechanism responsible for delayed lead perfor-
ation remains unclear. Mechanisms responsible for RV lead 
perforation generally involve lead-related factors such as the 
stiffness and diameter of the lead as well as myocardium-re-
lated factors such as morphology of the right ventricular wall 
and contraction during each heart beat.
5) Patients with thin-
ning of the ventricular wall are at a higher risk of lead perfor-
ation. Several reports have demonstrated that delayed lead-re-
lated complications such as lead perforation and lead failures 
were more frequent with the use of small-caliber ICD leads, 
especially the St. Jude Riata leads,
6) than with standard-caliber 
ICD leads,
7) thereby suggesting the important contribution 
of lead-related factors. In the present case, thinning of RV wall 
due to an old myocardial infarction caused by occlusion of the 
proximal right coronary artery might have critically contrib-
uted to the occurrence of lead perforation, since the stan-
dard-caliber active fixation lead (model 6947, Sprint Quattro 
8.6-French lead, Medtronic) was implanted at the RV apex. 
The incidence of ICD lead perforation has been reported to 
be approximately 0.5% in two independent studies including 
593 and 3,340 cases, respectively.
8)9) As previous reports have 
shown, lead perforation commonly occurred within 7 to 10 
days after implantation, mostly occurring at the time of impl-
antation or within the first 24 hours.
6)8) In addition, small-cali-
ber ICD leads were used in many of the recently reported cas-
es of lead perforation. Given the type of implanted ICD leads 
used and the timing of RV perforation, this is a rare case of ICD 
lead perforation clearly displayed by MDCT. 
With respect to the treatment of lead perforation, transve-
nous lead extraction under transesophageal echocardiogra-
phic monitoring might be a standard procedure, in case of ac-
tive-fixation lead.
1) However, we considered the present case 
to be at a high risk for hemodynamic and/or uncontrollable 
bleeding complications, because of decreased LV function 
with severe mitral regurgitation and dual anti-platelet therapy. 
Thus, we selected open surgery via median sternotomy as 
the safest approach. 
Operators of ICD implantation should always keep in mind 
that pericardial effusion due to lead perforation may develop 
without the typical manifestations of cardiac tamponade in 
the chronic phase.
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